Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine

NCT01964183 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of Mirabegron and Tolterodine
Healthy

Interventions

DRUG: tolterodine
DRUG: mirabegron

Sponsor

Astellas Pharma Inc